Patents by Inventor Gregory S. Erman

Gregory S. Erman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9138521
    Abstract: An ultrafiltration device and method for the removal of excess fluid in hypervolemic patients and/or removal of toxins in the blood including for patients suffering from either renal or cardiovascular disease is disclosed. An embodiment of the device includes a housing containing multiple large bore hollow fiber membranes which are connected to the patient's vascular system via a connecting element comprising bifurcated fluid pathway elements to physiologically channel the blood flow either to or from each hollow fiber membrane of the device, a channel to direct the fluid removed by the device to a suitable collection container or the patient's bladder, and controls that control excessive removal of the water from the patient. Devices can be either worn extracorporeally or surgically implanted in order to allow for continuous fluid removal with ambulatory freedom.
    Type: Grant
    Filed: June 25, 2012
    Date of Patent: September 22, 2015
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Barry A. Solomon, Gregory S. Erman, Frank A. Fazio
  • Publication number: 20120265118
    Abstract: An ultrafiltration device and method for the removal of excess fluid in hypervolemic patients and/or removal of toxins in the blood including for patients suffering from either renal or cardiovascular disease is disclosed. An embodiment of the device includes a housing containing multiple large bore hollow fiber membranes which are connected to the patient's vascular system via a connecting element comprising bifurcated fluid pathway elements to physiologically channel the blood flow either to or from each hollow fiber membrane of the device, a channel to direct the fluid removed by the device to a suitable collection container or the patient's bladder, and controls that control excessive removal of the water from the patient. Devices can be either worn extracorporeally or surgically implanted in order to allow for continuous fluid removal with ambulatory freedom.
    Type: Application
    Filed: June 25, 2012
    Publication date: October 18, 2012
    Applicant: Fresenius Medical Care Holdings, Inc.
    Inventors: Barry A. Solomon, Gregory S. Erman, Frank A. Fazio
  • Patent number: 8241239
    Abstract: An ultrafiltration device and method for the removal of excess fluid in hypervolemic patients and/or removal of toxins in the blood including for patients suffering from either renal or cardiovascular disease is disclosed. An embodiment of the device includes a housing containing multiple large bore hollow fiber membranes which are connected to the patient's vascular system via a connecting element comprising bifurcated fluid pathway elements to physiologically channel the blood flow either to or from each hollow fiber membrane of the device, a channel to direct the fluid removed by the device to a suitable collection container or the patient's bladder, and controls that control excessive removal of the water from the patient. Devices can be either worn extracorporeally or surgically implanted in order to allow for continuous fluid removal with ambulatory freedom.
    Type: Grant
    Filed: February 23, 2009
    Date of Patent: August 14, 2012
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Barry A. Solomon, Gregory S. Erman, Frank A. Fazio
  • Publication number: 20090234266
    Abstract: An ultrafiltration device and method for the removal of excess fluid in hypervolemic patients and/or removal of toxins in the blood including for patients suffering from either renal or cardiovascular disease is disclosed. An embodiment of the device includes a housing containing multiple large bore hollow fiber membranes which are connected to the patient's vascular system via a connecting element comprising bifurcated fluid pathway elements to physiologically channel the blood flow either to or from each hollow fiber membrane of the device, a channel to direct the fluid removed by the device to a suitable collection container or the patient's bladder, and controls that control excessive removal of the water from the patient. Devices can be either worn extracorporeally or surgically implanted in order to allow for continuous fluid removal with ambulatory freedom.
    Type: Application
    Filed: February 23, 2009
    Publication date: September 17, 2009
    Applicant: Fresenius Medical Care Holdings, Inc.
    Inventors: Barry A. Solomon, Gregory S. Erman, Frank A. Fazio